ShareValue scores for NSB.AU: Valuation 47, Quality 53, Growth 53, Health 56.
NSB.AUASX
Neuroscientific Biopharmaceuticals Ltd
A$0.06
(-6.25%)
NSB.AUASX
Neuroscientific Biopharmaceuticals Ltd
A$0.06(-6.25%)
Loading chart...
Sentiment
Verdicts
Value:Fair Value
Quality:Moderate
Growth:Moderate
Health:Moderate
Verdicts
Fundamental Rating
Value Trap Risk
Expected Return
6% to 16%
Rating
Trap Risk
Return
6% to 16%
Valuation
47
Fair Value
Price vs Value
Quality
53
Moderate
Business Strength
Growth
53
Moderate
Revenue & Earnings
Health
56
Moderate
Financial Stability
Momentum
50
Neutral
Price Trend
Company Details
About
NeuroScientific Biopharmaceuticals Limited engages in the research and development of biomedical products targeting neurodegenerative conditions. Its lead product is the EmtinB drug for the treatment of optic nerve diseases, such as glaucoma. The company also develops StemSmart platform technology to treat inflammatory immune disorders. NeuroScientific Biopharmaceuticals Limited was incorporated in 2002 and is based in Perth, Australia.
Market Cap$23M
P/E RatioN/A
Dividend YieldNone
Sector Rank#1099
Score Analysis
AI Investment Thesis
Data as of:Jun 29, 2026
|Last calculated:Jun 29, 2026